NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE152069 Query DataSets for GSE152069
Status Public on Jun 24, 2021
Title Combined inhibition of EZH2 and degradation of Ikaros has synergistic effects in germinal center B-cell diffuse large B-cell lymphoma
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Summary This SuperSeries is composed of the SubSeries listed below.
 
Overall design Refer to individual Series
 
Citation(s) 34168051
Submission date Jun 08, 2020
Last update date Sep 23, 2021
Contact name Robert Kridel
Organization name Princess Margaret Cancer Centre
Street address 101 College Street, Rm 12-311
City Toronto
State/province ON
ZIP/Postal code M5G 1L7
Country Canada
 
Platforms (2)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
GPL21697 NextSeq 550 (Homo sapiens)
Samples (40)
GSM4586536 SY1_DM_1: SUDHL4 DMSO
GSM4586537 SY1_DM_2: SUDHL4 DMSO
GSM4586538 SY1_LN_1: SUDHL4 lenalidomide
This SuperSeries is composed of the following SubSeries:
GSE151607 Combined inhibition of EZH2 and degradation of Ikaros has synergistic effects in germinal center B-cell diffuse large B-cell lymphoma [RNA-seq]
GSE152028 Combined inhibition of EZH2 and degradation of Ikaros has synergistic effects in germinal center B-cell diffuse large B-cell lymphoma [ChIP-seq]
Relations
BioProject PRJNA638187

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE152069_RAW.tar 6.2 Gb (http)(custom) TAR (of BEDGRAPH, TXT, XLS)
SRA Run SelectorHelp
| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap